Thrombosis, embolism, and hemorrhage are the three major causes of cerebrovascular accident (CVA). Thrombosis usually occurs in middle-aged and elderly people. CVA occurs when blood vessels are obstructed. Typically, the main site of the obstruction is the extra-cerebral or intra-cerebral vessels.
Embolism can occur at any age, especially among patients with a history of rheumatic heart disease, endocarditis, post transmatic valvular disease, myocardial fibrillation, and other cardiac arrhythmias, or after open-heart surgery. Usually it occurs in the left middle cerebral arteries.
|
Hemorrhage also occurs in middle-aged and elderly people, sudden rupture of a cerebral artery from hypertension or aneurysms will cause hemorrhage and endanger one’s life. Clinical Pharmacology of Breviscapini® Breviscapini® is formulated by using the effective elements extracted from an herb named Erigeron Breviscapinus, and it has been prescribed for centuries to treat cerebrovascular disorders. Many patients get a second chance of life after taking Breviscapini™ when they have cerebrovascular complications. Thus, named LIFEFLOWER™ Breviscapini® has been proven in many
pharmacological studies . It has conspicuous biological activities that
increase cerebrovascular blood flow. Other functions such as: |
Whole plant extract from Erigeron breviscapus, a native plant found only in the mountains over elevation of 3000m. |
Over 10 million clinical cases (aged 30-85 years) have proved that Breviscapini® is highly effective in cerebrovascular disorders, including cerebral embolism, and blood-brain barrier diseases, It is important to note that 82% clinical cases reported improvement in their state of cerebrovascular diseases. *
| *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure, treat, or prevent any disease. |